Progressing e-health and patient centered health care through patient near plasma sampling
|Funding from Vinnova||SEK 2 999 186|
|Project duration||June 2019 - May 2021|
|Venture||Swelife and Medtech4Health - Collaborative Projects for Improved Health|
|Call||Swelife and Medtech4Health - Collaborative Projects for Improved Health (Spring 2019)|
Purpose and goal
The project will develop a system for quantitative plasma sampling which the patient can take by themselves at home through a finger prick and send via regular mail to the laboratory for analysis. The objective is to increase access to health care for patients through rationalizing current processes for blood sampling and handling. This is achieved by eliminating costly and cumbersome steps associated with conventional blood sampling such as travelling to health care centers, that a trained nurse is needed for venipuncture and that the sample needs cooled transportation to the lab.
Expected results and effects
The result of the project enables true patient-centric digital health care solutions as these still are depending on the patient transporting him- or herself to a health care center for the blood sampling. The patient-centric diagnosis process would lower costs for the health care system as well as save patients time and effort and consequently result in increased access to health care in the society. The product is also expected to contribute to a reduction in CO2 emission and energy consumption as self-sampling reduces transportation of both patients and samples.
Planned approach and implementation
Capitainer AB has developed a prototype for quantitative plasma sampling from a finger prick. In the project, it will be further developed into a CE labelled product. For enabling implementation in laboratory routine, novel analysis methods on samples taken with the product needs to be developed.Karolinska University Hospital and Linköping University will evaluate the platform for detection of markers in clinical chemistry and therapeutic drug monitoring. Methods for detection of Albumin, Vitamin-D, CDT (alcohol marker) and antiepileptic drugs will be developed on the system.